Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 14/20 | 0.50 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.44 |
| ▸ | KMO | O15229 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3725418 | 0.84 | SCN9A (0.57) | SCN9AFPR2CASP1ADORA3PARP1 | |
| SCHEMBL3718638 | 0.80 | SCN9A (0.49) | SCN9ACYP2C9SCN5AKMOFPR2 | |
| SCHEMBL3721217 | 0.80 | SCN9A (0.53) | SCN9AFPR2CASP1ADORA3PARP1 | |
| SCHEMBL3721149 | 0.79 | USP1 (0.45) | CYP2C9CYP2D6MAOB | |
| SCHEMBL3717917 | 0.78 | SCN9A (0.53) | SCN9AFPR2CASP1ADORA3PARP1 | |
| SCHEMBL3724727 | 0.78 | SCN9A (0.53) | SCN9AFPR2CASP1ADORA3KDM4E | |
| SCHEMBL3728860 | 0.77 | SCN9A (0.56) | SCN9AFPR2ADORA3PARP1 | |
| SCHEMBL3727410 | 0.77 | SCN9A (0.53) | SCN9AKMOFPR2CASP1ADORA3 | |
| SCHEMBL3720121 | 0.76 | SCN9A (0.55) | SCN9AFPR2CASP1ADORA3KDM4E | |
| SCHEMBL3724700 | 0.74 | SCN9A (0.51) | SCN9AFPR2CASP1ADORA3PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8614201-B2 | Heterocyclic amides as modulators of TRPA1 | JANSSEN PHARMACEUTICA NV (BE) | 2013-12-24 | — | — | US | claimed |
| WO-2010141805-A1 | HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 | JANSSEN PHARMACEUTICA NV (BE) | 2010-12-09 | — | — | WO | claimed |
| US-8614201-B2 | Heterocyclic amides as modulators of TRPA1 | JANSSEN PHARMACEUTICA NV (BE) | 2013-12-24 | — | — | US | disclosed |
| WO-2010141805-A1 | HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 | JANSSEN PHARMACEUTICA NV (BE) | 2010-12-09 | — | — | WO | disclosed |